Inappropriate dose of enteral antimicrobials promotes resistance

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1644-

  Silvestri, L ^a   Negri, C ^b   Taylor, N ^c   Zandstra, D F ^d   Van Saene, H K F ^c  

^a Unit of Anesthesia and Intensive Care   (Italy)

^b Unit of Infectious Diseases   (Italy)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d Department of Intensive Care Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; COLISTIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASEPSIS; BACTERIAL OVERGROWTH; ENTERAL DECONTAMINATION; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; LOW DRUG DOSE; NASOGASTRIC TUBE; NONHUMAN; OROPHARYNX; PASTE; PRIORITY JOURNAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GASTROINTESTINAL TRACT; MALE; MICROBIOLOGY; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COLISTIN; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GASTROINTESTINAL TRACT; HUMANS; MALE;

EID: 84876765423     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00152-13     Document Type: Letter

References (8)

1. Brink AJ, Coetzee J, Corcoran C, Clay CG, Hari-Makkan D, Jacobson RK, Richards GA, Feldman C, Nutt L, van Greune J, Deetlefs JD, Swart K, Devenish L, Poirel L, Nordman P. 2013. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J. Clin. Microbiol. 51: 369-372.
2. Silvestri L, de la Cal MA, van Saene HKF. 2012. Selective decontamination of the digestive tract: the mechanism of action is control of overgrowth. Intensive Care Med. 38:1738-1750.
3. Falagas ME, Kasiakou SK. 2006. Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world. Antimicrob. Agents Chemother. 50:2274-2275.
4. van Saene JJM, van Saene HKF, Tarko-Smit NJP, Beukeveld GJJ. 1988. Enterobacteriaceae suppression by three different oral doses of polymyxin E in human volunteers. Epidemiol. Infect. 100:407-417.
5. van Saene JJM, van Saene HKF, Stoutenbeek CP, Lerk CF. 1985. Influences of faeces on the activity of antimicrobial agents for decontamination of the alimentary canal. Scand. J. Infect. Dis. 17:295-300.
6. van Saene HKF, Taylor N, Damjanovic V, Sarginson RE. 2008. Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill. Curr. Drug Targets 9:419-421.
7. de Smet AMGA, Kluytmans JAJW, Cooper BS, Mascini EM, Benus RFJ, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJM, Bernards AT, Kuijper EJ, Joore JCA, Leverstein-van Hall MA, Bindels AJGH, Jansz AR, Wesselink RMJ, de Jongh BM, Dennesen PJW, van Asselt GJ, te Velde LF, Frenay IHME, Kaasjager K, Bosch FH, van Iterson M, Thijsen SFT, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LPHJ, Sturm PDJ, Harinck HIJ, Voss A, Uijtendaal EV, Blok HEM, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJM. 2009. Decontamination of the digestive tract and oropharynx in ICU patients. N. Engl. J. Med. 360:20-31.
8. Oostdijk EAN, Smits L, de Smet AMGA, Leverstein-van Hall MA, Kesecioglu J, Bonten MJM. 2012. Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units. Intensive Care Med. [Epub ahead of print.] doi:10.1007/s00134-012-2761-3.